Intensive Care Management of Myasthenia Gravis Complicated by Endemic Goiter (A Clinical Case)
https://doi.org/10.22448/AMJ.2025.2.56-60
EDN: NLHYQH
Abstract
This article presents up-to-date information on the epidemiology, pathogenesis, diagnosis, and intensive care management of myasthenia gravis, along with a clinical case of a female patient with myasthenia gravis coexisting with endemic goiter. Particular emphasis is placed on the therapeutic roles of plasmapheresis, intravenous immunoglobulin, and corticosteroids in the treatment of acute myasthenic exacerbations.
About the Authors
S. V. Khodus
Amur State Medical Academy of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Sergey V. Khodus
Blagoveshchensk
I. V. Barabash
Amur State Medical Academy of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Irina V. Barabash
Blagoveshchensk
A. A. Stukalov
Amur State Medical Academy of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Anatoly A. Stukalov
Blagoveshchensk
A. P. Yelchin
Amur State Medical Academy of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Anatoly P. Yelchin
Blagoveshchensk
References
1. Punga A.R., Maddison P., Heckmann J.M., et al. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurology. 2022; 21 (2): 176–188. DOI: https://doi.org/10.1016/S1474-4422(21)00297-0
2. Pipiya N.S., Tantsorov A.A. Myasthenia gravis: clinical aspects and differential diagnosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2018; 118 (5): 78–85. (In Russ.)
3. Bubuioc A-M., Kudebayeva A., Turuspekova S., et al. The epidemiology of myasthenia gravis. Journal of Medicine and Life. 2021; 14 (1): 7–16. DOI: https://doi.org/10.25122/jml-2020-0145
4. Carr A.S., Cardwell C.R., McCarron P.O., McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurology. 2010; 10: 46. DOI: https://doi.org/10.1186/1471-2377-10-46
5. Alhaidar M.K., Abumurad S., Soliven B., Rezania K. Current Treatment of Myasthenia Gravis. Journal of Clinical Medicine. 2022; 11 (6): 1597. DOI: https://doi.org/10.3390/jcm11061597
6. Zavalishin I.A., Peresedova A.V. Modern approaches to the diagnosis and treatment of myasthenia gravis. Neurological Journal. 2015; 20 (3): 15–22. (In Russ.)
7. Sussman J., Farrugia M.E., Maddison P., et al. Myasthenia gravis: Association of British Neurologists’ management guidelines. Practical Neurology. 2015; 15 (3): 199–206. DOI: https://doi.org/10.1136/practneurol-2015-001126
8. Kutashov V.A., Boyko A.N. Myasthenia gravis: modern aspects of pathogenesis and treatment. Neurology, neuropsychiatry, psychosomatics. 2019; 11 (2): 12–18. (In Russ.)
9. Mendibaev M.S., Lykhin V.N., Rabodinsky S.E., Ageev P.V. Extracorporeal blood purification in in-tensive care. Moscow: GEOTAR-Media, 2024. 368 p. (In Russ.)
10. Lobzin V.S., Saykova L.A., Polyakova et al. Criteria for the severity and prognosis of myasthenia gravis. Journal of Neuropathology and Psychiatry. 1985; 85 (11): 1625–1631. (In Russ.)
11. Skvortsova V.I., Ivanova G.E. Myasthenia gravis and myasthenic syndromes. Moscow: GEOTAR-Media, 2010. (In Russ.)
Review
For citations:
Khodus S.V., Barabash I.V., Stukalov A.A., Yelchin A.P. Intensive Care Management of Myasthenia Gravis Complicated by Endemic Goiter (A Clinical Case). Amur Medical Journal. 2025;13(2):56-60. (In Russ.) https://doi.org/10.22448/AMJ.2025.2.56-60. EDN: NLHYQH
Views:
16
JATS XML
Email this article 